Immgenuity, Inc. is a biotechnology company dedicated to developing innovative immunotherapy solutions to improve the lives of patients suffering from HIV. The company’s lead product candidate is IMTV014, a novel immunotherapy for HIV and NeuroAIDS, which has been shown to be safe in preclinical studies. Immgenuity, Inc. is headquartered in Dover, Delaware, and is led by a team of experienced biotech professionals with deep ...
Immgenuity, Inc. is a biotechnology company dedicated to developing innovative immunotherapy solutions to improve the lives of patients suffering from HIV. The company’s lead product candidate is IMTV014, a novel immunotherapy for HIV and NeuroAIDS, which has been shown to be safe in preclinical studies. Immgenuity, Inc. is headquartered in Dover, Delaware, and is led by a team of experienced biotech professionals with deep expertise in infectious diseases, immunology, virology, and drug development.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.